Meta-analysis shows lower incidence of future stroke, major bleeding versus warfarin
BOSTON -- Apixaban (Eliquis) may be better than warfarin (Coumadin) for lowering the incidence of systemic embolism, stroke, and major bleeding in patients with stage 4 or 5 chronic kidney disease (CKD) and atrial fibrillation (Afib), a meta-analysis found.